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a  b  s  t  r  a  c  t
2,5-Di-(tert-butyl)-1,4-benzohydroquinone  (TBQ)  is a reversible  inhibitor  of SERCA,  potentially  making  it
a  useful  tool  to study  the effects  of  SERCA  inhibition  in cardiac  cells.  However,  it is  unknown  if TBQ  also  has
effects  on  other  components  of ventricular  Ca handling.  The  aim  of these  experiments  was to characterise
the  effects  of  TBQ on  Ca handling  in rat  ventricular  myocytes  and  assess  its suitability  as  a specific  inhibitor
of  SERCA.  This  was  achieved  by voltage  clamp  via  perforated  patch  and  [Ca2+]i measurement  using  Fluo-3
AM.  TBQ  produced  a fully  reversible,  concentration  dependent  decrease  in  the rate  of systolic  Ca  decay.
10  M  TBQ  decreased  the amplitude  of  the  systolic  Ca transient  by 48 ± 5% and the  rate  of  decay  by
54 ± 6%.  SR  Ca  content  was also  reduced  by 62  ± 4%.  However,  10 M TBQ  also  decreased  the  peak  L-type
Ca  current  by  23  ±  7%.  At  higher  concentrations  (100 M), TBQ  also  activated  an  outward  current  with ayocyte current–voltage  relationship  consistent  with  a  potassium  current.  This  outward  current  was  abolished
by  Glibenclamide  (100  M).  These  data  show  that  TBQ  can be  used  to  reversibly  inhibit  SERCA.  However,
at  concentrations  that decrease  SERCA  activity,  TBQ  also decreases  the  L-type  Ca current  and  (at higher
concentrations)  activates  an outward  current  which  appears  to be  an  ATP dependent  potassium  current.
We  conclude  that TBQ  cannot  be used  as  a specific  inhibitor  of  SERCA  in rat  ventricular  myocytes.
©  2015  The  Authors.  Published  by Elsevier  Ltd. This  is an open  access  article  under  the  CC BY  license. Introduction
For the heart to function as a pump, the myocardium must relax
ollowing systole. At the cell level, this is achieved by removal of sys-
olic Ca from the cytosol restoring diastolic Ca levels. In mammals,
he majority of Ca removal occurs by reuptake of Ca into the sar-
oplasmic reticulum (SR) by the sarco-endoplasmic reticulum Ca
TPase (SERCA) [1]. In rat cardiac myocytes, SERCA uptake accounts
or around 90% of the total cytosolic Ca removal, with the remain-
er due to the Na–Ca exchange (NCX) and the plasma membrane
a-ATPase (PMCA) [2].
During conditions such as metabolic inhibition [3] and heart
isease [4], both contraction and relaxation may  be affected.
ecreased relaxation (negative lusitropy) has been attributed
o impaired SERCA function and thence a slowing of systolic
a removal [4,5]. Studying the role of SERCA requires, ide-
lly, a selective and reversible inhibitor. Thapsigargin has been
sed extensively [6–8] but its actions are irreversible. Another
∗ Corresponding author. Tel.: +44 161 295 2170.
E-mail address: d.j.greensmith@salford.ac.uk (D.J. Greensmith).
1 These authors contributed equally to this work.
ttp://dx.doi.org/10.1016/j.ceca.2015.05.002
143-4160/© 2015 The Authors. Published by Elsevier Ltd. This is an open access article u(http://creativecommons.org/licenses/by/4.0/).
inhibitor is 2,5-di-(tert-butyl)-1,4-benzohydroquinone (TBQ). This
is reversible and has been used previously in many cell types
including ventricular myocytes and muscle preparations [9,10].
However, it is currently unknown whether TBQ has an effect on
other Ca handling components of ventricular myocytes. The aim of
the present study was to characterise the effects of TBQ on intra-
cellular Ca handling in rat ventricular myocytes and to assess the
suitability of TBQ as a specific inhibitor of SERCA.
We demonstrate that, in addition to inhibiting SERCA, TBQ
decreases ICa-L and activates an outward potassium current leaving
its suitability as a specific SERCA inhibitor in question.
2. Methods
2.1. Isolation of ventricular myocytes
Rat ventricular myocytes were isolated by enzymatic diges-
tion. Male Wistar rats (weighing approximately 200 g) were killed
in accordance with the Animals (Scientific Procedures) Act 1982.
Hearts were quickly excised and mounted on a Langendorff appa-
ratus by aortic cannulation to allow retrograde perfusion of the
coronary arteries. The heart was perfused with a calcium free
solution containing (in mM)  NaCl; 134, HEPES; 10, Glucose; 11.1,
nder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Fig. 1. The effects of TBQ on the Ca transient. (A) Specimen [Ca2+]i transients measured with Fluo-3. The cell was stimulated at 0.5 Hz with a 100 ms  duration depolarising
pulse  from −40 to 0 mV.  TBQ was applied in the concentrations shown. (B) Expanded time base overlays showing averaged transients from (A). Left shows original records
and  right normalised. (C) Average data (n = 16 cells from 8 animals) showing (left) the amplitude of systolic Ca and (right) rate constant of decay of systolic Ca. All data have
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aH2PO4; 1.2, MgSO4; 1.2, KCl; 4 (titrated to pH 7.34 at room
emperature). Following a 5 min  wash with Ca free solution, Col-
agenase (Worthington Biochemical Cooperation, NJ, USA) and
rotease (Sigma–Aldrich, Dorset, UK) were added to the perfusate
t concentrations of 95.4 units/mg and 0.1 units/mg respectively for
 min. The ventricles were then removed and minced in a Taurine
olution containing (in mM)  NaCl; 115, HEPES; 10, Glucose; 11.1,
aH2PO4; 1.2, MgSO4; 1.2, KCl; 4, Taurine; 50 (titrated to pH 7.34
t room temperature). Gentle agitation was used to release single
yocytes. Cells were stored in Taurine solution at room tempera-
ure prior to use.
.2. Electrophysiological recordings
Myocytes were voltage clamped using the perforated patch
echnique (Axon Instruments, CA, USA). Microelectrodes (resis-
ance 4–5 M)  were filled with solution consisting of (in mM);
0 NaCl; 20 KCl; 10 HEPES; 125 K3CH3O3S; 5 MgCl2; 0.1 K2EGTA
titrated to pH 7.2 using KOH) and 240 g/ml amphotericin B.
nless otherwise stated, cells were stimulated with a 100 ms
uration voltage step from a holding potential of −40 mV  to
 mV,  at a frequency of 0.5 Hz using pClamp software (Axonoving the final concentration of TBQ (*p < 0.05 vs. control).
Instruments, CA, USA). Cells were bathed in a standard experi-
mental solution (134 mM NaCl, 10 HEPES, 11.1 Glucose, 1.2 MgCl2,
4 KCl, 1 CaCl2, titrated to pH 7.34 at room temperature). Most
experiments were performed at 37 ◦C. TBQ (Sigma–Aldrich, Dorset,
UK) was  applied at final concentrations of 1, 3, 10 and 100 M
from a 100 mM stock in ethanol. Control experiments (data not
shown) demonstrated that 0.1% ethanol (the highest concentra-
tion applied to cells) had no observable effect on any measured
parameter.
2.3. Measurement of intracellular Ca and SR Ca content
Myocytes were loaded with the membrane permeable ace-
toxymethyl (AM) ester form of the fluorescent Ca indicator Fluo-3
(5 mol/L for 10 min). Fluo-3 was  excited at 488 nm and emitted
fluorescence measured with a 515 nm long pass filter. Background
fluorescence was subtracted from all signals. Changes in [Ca2+]i
are represented by changes in fluorescence expressed as: F/F0,
where F0 is control, diastolic fluorescence. SR Ca content was
measured by rapid application of 10 mM caffeine and integration
of the resulting inward NCX current as described previously in
detail [11].
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iig. 2. The effect of TBQ on SR Ca content. (A) Specimen INCX records (top panel) an
voked by rapid application of 10 mM caffeine (white bar). (B) Average SR Ca (n = 5 
.4. Data analysis and statistics
Data were analysed with custom written Excel routines [12].
esults are expressed as mean data ± SEM for n cells. Statistical
ignificance (p < 0.05) was determined using t-tests and repeated
easures ANOVAs.
. Results
The experiment illustrated in Fig. 1 (representative of data from
6 cells) shows the effect of TBQ on Ca transients evoked by depo-
arising pulses. TBQ produced a concentration dependent decrease
n the amplitude of systolic Ca and rate of systolic Ca decay and an
ncrease of diastolic Ca (Fig. 1A). The effects on the kinetics of the
a transient can be seen more clearly in the fast time base records
f Fig. 1B. Average data from these experiments are presented in
ig. 1C.
10 M TBQ was used to study the effect on SR Ca content. This
oncentration was used as it decreased SERCA activity without
arkedly reducing the systolic Ca transient. Fig. 2A (representative
f 5 cells) shows specimen NCX currents (top) produced by rapid
pplication of 10 mM caffeine in control and following TBQ and
he integrals of those currents (below). TBQ consistently decreased
his integral. On average (Fig. 2B) TBQ decreased SR Ca content by
2 ± 4%.In these experiments we also found that application of TBQ had
arked effects on membrane current. The current records illus-
rated in Fig. 3A were recorded at the same time as the Ca transients
n Fig. 1. Application of TBQ produced a concentration dependentesponding integrals (lower panel) in control (left) and following 10 M TBQ (right)
rom 3 animals, *p < 0.05 vs. control).
decrease of peak ICa-L (mean data shown as black trace in Fig. 3B).
Fig. 3C shows the effect of 10 M TBQ on the mean I–V relationship
of ICa-L. TBQ decreased ICa-L amplitude over the entire voltage range
tested but did not shift the IV relationship. At higher concentrations
(100 M,  Fig. 3A), application of TBQ also resulted in the appear-
ance of an outward current (see also average data in Fig. 3D). In
order to study the outward current in more detail, in some exper-
iments we applied a depolarising voltage ramp. Fig. 3E shows the
resulting current under control conditions and following exposure
to 100 M TBQ. Subtraction of the control current from that pro-
duced by TBQ gives the TBQ sensitive current. This experiment was
typical of 5 cells.
One concern with the interpretation of the results of Fig. 3A–C
is the possibility that, at least at higher concentrations of TBQ, the
apparent decrease of inward current resulted from the increase of
outward current. We  discovered that the outward current could
be inhibited by Glibenclamide (100 M).  The specimen current
records of Fig. 4A were recorded from a cell where 100 M TBQ was
applied to replicate the effect observed in the experiment of Fig. 3.
Again, TBQ decreased the inward current and increased the out-
ward. Subsequently, TBQ was  removed, and 100 M Glibenclamide
applied. 100 M TBQ was  then re-applied (in the maintained pres-
ence of 100 M Glibenclamide). In the presence of Glibenclamide,
the reduction of ICa-L produced by TBQ persisted; however, the acti-
vation of the outward component was  prevented. Glibenclamide
alone produced no effect on the calcium current (0.44 ± 0.09 vs.
0.48 ± 0.14 nA, n = 5, p > 0.05; data not shown). Average data for
4 cells are shown in Fig. 4B. The experiments of Fig. 4C were car-
ried out to determine if 10 M TBQ had a direct effect on the L-type
Ca current or, alternatively, whether the effects were an indirect
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Fig. 3. The effects of TBQ on sarcolemmal currents. (A) Specimen membrane currents in response to a 100 ms  depolarising pulse from −40 to 0 mV. Panels show (left to right)
control,  increasing concentrations of TBQ and washout. (B) Average data (n = 17 cells from 8 animals) showing peak inward current (black). The effect on the rate constant
of  systolic calcium removal is superimposed for reference (grey and dashed curve). (C) ICa-L I–V plot in control (open symbols) and presence of 10 M TBQ (filled symbols).
(D)  Average data shows the peak outward component of the currents represented by (A). (E) Specimen IV relationship produced by a voltage ramp protocol (−120 to 40 mV)
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ohowing the control current, the current after exposure to TBQ and the TBQ sensitiv
xperiments. *p < 0.05 vs. control.
onsequence of changes of cellular Ca handling resulting from inhi-
ition of SERCA. 10 M TBQ was chosen for the reasons stated
bove. Fig. 4C shows a current trace recorded from a cell where
a in the external solution had been replaced by Ba. On average
Fig. 4D) peak IBa was reduced by 27.7 ± 4.6%.
The final question addressed was whether the effects on mem-
rane current were a direct effect of TBQ or, alternatively, secondary
o SERCA inhibition. In parallel experiments illustrated in Fig. 5,
his was done by examining the effects of 1 M Thapsigargin,
n alternative SERCA inhibitor. Thapsigargin, decreased both the
mplitude and rate of decay of systolic Ca to levels comparable
o those produced by 100 M TBQ as shown in Fig. 1 (Ca tran-
ient amplitude: TBQ 11.8%, Thapsigargin: 15.1% of control. Rate
f systolic Ca decay: TBQ 22.1%, Thapsigargin 8.75% of control).
n the presence of Thapsigargin, however, these effects were not
ssociated with a decreased ICa-L or activation of Io. A consistent
lowed ICa-L inactivation was observed, consistent with a decreased
ystolic Ca.. Discussion
The original aim of this study was to characterise the effects
f TBQ on intracellular Ca handling in rat cardiac myocytes toent determined by subtraction of TBQ from control (ITBQ). This record is typical of 5
determine whether TBQ is suitable for use as a specific inhibitor
of SERCA. The results show that TBQ decreases the Ca current and
activates an outward current; these effects must be born in mind
when using this compound.
4.1. The effect of TBQ on intracellular calcium
As expected, TBQ produced a reversible and concentration
dependent decrease in both the rate of decay of the systolic Ca
transient and the SR Ca content; effects consistent with SERCA
inhibition. Previously we have shown that in cardiac myocytes
exhibiting spontaneous waves of SR Ca release, SERCA inhibition
by 100 M TBQ, produced only a small decrease (to 94% of con-
trol) of SR Ca content immediately prior to the onset of a Ca wave
[9]. The above reduction of SR Ca content to 38% produced by TBQ,
demonstrates that SERCA inhibition in stimulated cells causes a
greater disruption to Ca cycling; presumably due to the finite time
available for the SR to refill following CICR. TBQ also produced a
concentration dependent decrease in systolic Ca and an increase
in diastolic Ca, the latter presumably as a result of severe SERCA
impairment resulting in incomplete removal of systolic Ca on each
beat.
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Fig. 4. Characterisation of sarcolemmal currents produced by TBQ. (A) Specimen current records. The cell was  stimulated at 0.5 Hz with a 100 ms  duration depolarising pulse
from  −40 to 0 mV.  Currents were recorded in control then exposed to 100 M TBQ. TBQ was then washed off and 100 M Glibenclamide added before adding 100 M TBQ
with  100 M Glibenclamide. (B) Average data (n = 4 cells from 3 animals) showing (left) the amplitude of the outward component and (right) the amplitude of the inward
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.2. The effect of TBQ on membrane currents
TBQ produced a concentration dependent decrease of peak ICa-L
Fig. 3); this inhibition was  seen at all membrane potentials exam-
ned (Fig. 3C). When Ca was replaced with Ba, TBQ also decreased
eak IBa (Fig. 4C and D) suggesting a direct effect of TBQ on the
-type Ca channel may  contribute to the decreased peak ICa-L.
As well as decreasing the inward current, TBQ increased
he outward current at the end of the depolarising pulse. The
urrent–voltage relationship confirms that TBQ increases an out-
ard current (as opposed to decreasing an inward current). The
V relationship of the TBQ sensitive current (Fig. 3E) was consis-
ent with that of a potassium current. Furthermore, it appeared to
e weakly rectifying. One possible candidate for the current may
e an ATP dependent potassium current (IK-ATP) [13]. This would
e consistent with the complete inhibition of the outward current
y Glibenclamide [14] (Fig. 4). Such an increase of outward cur-
ent might be a direct effect of TBQ but it should also be noted that
BQ has been shown to decrease intracellular ATP [15] and might
hereby increase the current.
It is also important to note that, in the presence of Gliben-
lamide, although the outward component is inhibited, the
ecreased ICa-L persists. This confirms that the above effects on ICa-Lak IBa data (n = 4 cells from 4 animals) (*p < 0.05 vs. control).
are a direct effect of TBQ, rather than because the net inward current
recorded is simply being offset by a positive component.
4.3. The mechanism of the effect of TBQ on systolic Ca
Given the various effects of TBQ identified in this paper, it is
worthwhile considering their relative contributions to the observed
decrease of the Ca transient. One obvious explanation is provided by
the measured decrease of SR Ca content. Previous work has shown
that the amplitude of the systolic Ca transient is proportional to the
third power of SR Ca content [16]. Following application of 10 M
TBQ, SR Ca content fell to 38% of control (Fig. 2). This would predict
a reduction of systolic Ca to (0.38)3 = 5.5% control. Therefore, this
reduction in SR Ca content can more than explain the reduction of
systolic Ca to 52% of control produced by 10 M TBQ. In addition
to this, the decrease of L-type Ca current would produce a more
modest fall of the Ca transient [17].
4.4. Are the effects of TBQ on sarcolemmal currents due to SERCA
inhibition?
The decrease of ICa-L and activation of IK-ATP observed in the
presence of TBQ may  have been a consequence of SERCA inhibition
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[ig. 5. Does SERCA inhibition activate IK-ATP? (A) Specimen [Ca2+]i transients showin
he  decay phase. 1 M Thapsigargin was applied to inhibit SERCA. (B) Specimen ICa-
ssociated with a decrease in ICa-L or activation of Io. Representative of 3 cells from 
ather than a direct effect of TBQ. That this is not the case is demon-
trated by Fig. 5. Thapsigargin decreased both the amplitude and
ate of decay of systolic Ca to levels comparable to those produced
y TBQ. It did not, however, decrease the amplitude of ICa-L or
ctivate an outward current, indicating that these effects are not
econdary to SERCA inhibition. Thapsigargin decreased the rate
f decay of the L-type Ca current presumably due to decreasing
a-dependent inactivation.
.5. The suitability of TBQ as a specific SERCA inhibitor
That TBQ produces effects on sarcolemmal currents brings into
uestion whether it is a useful inhibitor of SERCA. Fig. 3B shows an
C50 for SERCA inhibition of about 10 M.  This concentration only
roduces an approx. 25% inhibition of ICa-L (IC50 approx. 40 M)
nd no measurable Io. The relatively high potency for SERCA inhi-
ition means TBQ may  be useful where partial, reversible inhibition
f SERCA is required or where membrane currents are controlled
r irrelevant (for example, in permeablised cells). However, con-
entrations which produce near complete inhibition of SERCA are
ssociated with an approx. 75% reduction in ICa-L, and an approx.
.1 fold increase in Io. The magnitude of these “unwanted” effects
hows that in the rat cardiac myocyte, TBQ is not a specific inhibitor
f SERCA, and may  be of limited practical use.
. Summary
This study confirms that TBQ is a reversible inhibitor of SERCA
n rat ventricular myocytes. However, in these cells, at concentra-
ions that reduce SERCA activity, TBQ also decreases peak ICa-L and
ctivates an outward current which we suggest is IK-ATP. We  there-
ore conclude that TBQ is unsuitable for use as a specific reversible
nhibitor of SERCA in cardiac myocytes.onflicts of interest
No conflicts of interest declared.
[inal traces (left panel) and normalised traces (right panel) for direct comparison of
s in control and following 1 M Thapsigargin. Application of Thapsigargin was not
als.
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